http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-37051-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fa68ae66fed2f54717da32e57f7735f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54
filingDate 1972-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1974-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-37051-L
titleOfInvention Histidine derivatives
abstract 1374317 Histidine derivative RECKITT & COLMANN PRODUCTS Ltd 28 Dec 1972 [20 Jan 1972] 2695/72 Heading C2C The novel compound, N-(cyclopentylcarbonyl - L - histidyl)pyrrolidine, and pharmaceutically acceptable acid addition salts thereof are prepared by reacting cyclopentanecarboxylic acid or reactive functional derivatives thereof with N-(L-histidyl)pyrrolidine, or by reacting pyrrolidine with N-(cyclopentylcarbonyl)-L-histidine or esters thereof. p-Nitrophenyl cyclopentanecarboxylate is obtained by reacting cyclopentanecarboxylic acid with p-nitrophenol in the presence of N,N<SP>1</SP>- dicyclohexylcarbodiimide. N - (L - Histidyl)pyrrolidine hydrochloride is obtained by hydrolysing N-(t-butoxycarbonyl- L-histidyl)pyrrolidine or the hydrogenolysis of N - (benzyloxycarbonyl - L - histidyl)pyrrolidine, both of which are prepared by reacting pyrrolidine with the appropriate L-histidine derivative. Pharmaceutical compositions contain the above novel compound or therapeutically acceptable acid addition salts thereof in association with pharmaceutically acceptable diluents or carriers. The compound inhibits the action of hypothalamic thyrotropin releasing hormone.n[GB1374317A]
priorityDate 1972-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID980
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID414344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453426087
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID266721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11321743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426133118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID532346
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451081191
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38065
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP17276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18840
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415998334
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22044
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62970
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54XS1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62971
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424493049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62968
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396959
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7098641
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159731529
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482269

Total number of triples: 45.